{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T23:57:05Z","timestamp":1780617425322,"version":"3.54.1"},"reference-count":178,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology: X"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.eurox.2025.100366","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:29:42Z","timestamp":1737678582000},"page":"100366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Management of menopausal hot flushes. Recommendations from the Spanish Menopause Society"],"prefix":"10.1016","volume":"25","author":[{"given":"M.","family":"Fasero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Baquedano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Gippini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Beltr\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lilue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Porcel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Pingarr\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Herrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Carretero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Palacios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.J.","family":"Coronado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.eurox.2025.100366_bib1","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ecl.2015.05.001","article-title":"Menopausal symptoms and their management","volume":"44","author":"Santoro","year":"2015","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"4","key":"10.1016\/j.eurox.2025.100366_bib2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1001\/jamainternmed.2014.8063","article-title":"Study of Women's Health Across the Nation. Duration of menopausal vasomotor symptoms over the menopause transition","volume":"175","author":"Avis","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"4","key":"10.1016\/j.eurox.2025.100366_bib3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"Guyatt GH. GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.eurox.2025.100366_bib4","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1210\/jcem-13-6-688","article-title":"Comparative clinical evaluation of estrogenics preparations by the menopausal and amenorrheal indices","volume":"13","author":"Kupperman","year":"1953","journal-title":"J Clin Endocrinal Metab"},{"issue":"1","key":"10.1016\/j.eurox.2025.100366_bib5","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1023\/A:1008973822876","article-title":"The Women's Health Questionnaire (WHQ): the development, standardization and application of a measure of mid-aged women's emotional and physical health","volume":"9","author":"Hunter","year":"2000","journal-title":"Qual Life Res"},{"issue":"1","key":"10.1016\/j.eurox.2025.100366_bib6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.maturitas.2007.10.010","article-title":"Validation of a menopause quality of life scale: the MENCAV scale","volume":"59","author":"Buend\u00eda Bermejo","year":"2008","journal-title":"Maturitas"},{"key":"10.1016\/j.eurox.2025.100366_bib7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/13697130009167599","article-title":"The menopause rating scale (MRS) comparison with Kupperman index and quality of life scale SF-36","volume":"3","author":"Scheneider","year":"2000","journal-title":"Climateric"},{"issue":"3","key":"10.1016\/j.eurox.2025.100366_bib8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0378-5122(96)82006-8","article-title":"A menopause-specific quality of life questionnaire: development and psychometric properties","volume":"24","author":"Hilditch","year":"1996","journal-title":"Maturitas"},{"issue":"11","key":"10.1016\/j.eurox.2025.100366_bib9","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1097\/GME.0000000000001223","article-title":"The Utian Quality of Life (UQOL) Scale: development and validation of an instrument to quantify quality of life through and beyond menopause.","volume":"25","author":"Utian","year":"2018","journal-title":"Menopause"},{"key":"10.1016\/j.eurox.2025.100366_bib10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0378-5122(98)00025-5","article-title":"Constructing a standard climateric scale","volume":"29","author":"Greene","year":"1998","journal-title":"Maturitas"},{"issue":"6","key":"10.1016\/j.eurox.2025.100366_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/S0025-7753(04)74198-6","article-title":"CV relacionada con la salud de la mujer espa\u00f1ola durante la perimenopausia y la postmenopausia. Desarrollo y validaci\u00f3n de la Escala Cervantes","volume":"122","author":"Palacios","year":"2004","journal-title":"Med Clin"},{"key":"10.1016\/j.eurox.2025.100366_bib12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.maturitas.2015.10.013","article-title":"Psychometric attributes of the Cervantes short-form questionnaire for measuring health-related quality of life in menopausal women","volume":"84","author":"Coronado","year":"2016","journal-title":"Maturitas"},{"key":"10.1016\/j.eurox.2025.100366_bib13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.maturitas.2021.01.004","article-title":"AEEM collaborative group for the study of psychometric validation of the Cervantes Short-Form. Population-based norms for the Cervantes-SF short-form questionnaire assessing health-related quality of life in menopause","volume":"146","author":"Coronado","year":"2021","journal-title":"Maturitas"},{"issue":"3","key":"10.1016\/j.eurox.2025.100366_bib14","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/GME.0000000000000321","article-title":"Structural validity of a 16-item abridged version of the Cervantes Health-Related Quality of Life scale for menopause: the Cervantes Short-Form Scale","volume":"22","author":"Coronado","year":"2015","journal-title":"Menopause"},{"issue":"2","key":"10.1016\/j.eurox.2025.100366_bib15","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1097\/GME.0000000000001790","article-title":"AEEM group for the development of the Cervantes-SF scale. Predictive and criterion validity of the Cervantes-SF menopause quality of life questionnaire","volume":"28","author":"Coronado","year":"2021","journal-title":"Menopause"},{"key":"10.1016\/j.eurox.2025.100366_bib16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.maturitas.2020.09.004","article-title":"Health-related quality of life and resilience in peri- and postmenopausal women during Covid-19 confinement","volume":"144","author":"Coronado","year":"2021","journal-title":"Maturitas"},{"issue":"3","key":"10.1016\/j.eurox.2025.100366_bib17","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/13697137.2021.1941849","article-title":"Effects of resistance training on quality of life in postmenopausal women with vasomotor symptoms","volume":"25","author":"Berin","year":"2022","journal-title":"Climacteric"},{"key":"10.1016\/j.eurox.2025.100366_bib18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.maturitas.2019.05.005","article-title":"Resistance training for hot flushes in postmenopausal women: a randomised controlled trial","volume":"126","author":"Berin","year":"2019","journal-title":"Maturitas"},{"issue":"5","key":"10.1016\/j.eurox.2025.100366_bib19","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/GME.0000000000001947","article-title":"A 16-week multicomponent exercise training program improves menopause-related symptoms in middle-aged women. The FLAMENCO project randomized control trial","volume":"29","author":"Baena-Garc\u00eda","year":"2022","journal-title":"Menopause"},{"issue":"2","key":"10.1016\/j.eurox.2025.100366_bib20","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3390\/jcm12020548","article-title":"The efficacy of strength exercises for reducing the symptoms of menopause: a systematic review","volume":"12","author":"Capel-Alcaraz","year":"2023","journal-title":"J Clin Med"},{"issue":"11","key":"10.1016\/j.eurox.2025.100366_bib21","article-title":"Exercise for vasomotor menopausal symptoms","volume":"2014","author":"Daley","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.eurox.2025.100366_bib22","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/1471-0528.13193","article-title":"The effectiveness of exercise as treatment for vasomotor menopausal symptoms: randomised controlled trial","volume":"122","author":"Daley","year":"2015","journal-title":"BJOG"},{"issue":"6","key":"10.1016\/j.eurox.2025.100366_bib23","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3109\/07853890.2011.583674","article-title":"Effect of aerobic training on hot flushes and quality of life--a randomized controlled trial","volume":"44","author":"Luoto","year":"2012","journal-title":"Ann Med"},{"issue":"4","key":"10.1016\/j.eurox.2025.100366_bib24","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.maturitas.2012.05.003","article-title":"Sleep quality and aerobic training among menopausal women--a randomized controlled trial","volume":"72","author":"Mansikkam\u00e4ki","year":"2012","journal-title":"Maturitas"},{"issue":"4","key":"10.1016\/j.eurox.2025.100366_bib25","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/01.GME.0000113932.56832.27","article-title":"Effect of a yearlong, moderate-intensity exercise intervention on the occurrence and severity of menopause symptoms in postmenopausal women","volume":"11","author":"Aiello","year":"2004","journal-title":"Menopause"},{"issue":"2","key":"10.1016\/j.eurox.2025.100366_bib26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0378-5122(03)00187-7","article-title":"Vasomotor symptoms and quality of life in previously sedentary postmenopausal women randomised to physical activity or estrogen therapy","volume":"48","author":"Lindh-Astrand","year":"2004","journal-title":"Maturitas"},{"issue":"5","key":"10.1016\/j.eurox.2025.100366_bib27","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.3945\/ajcn.112.049965","article-title":"Fruit, Mediterranean-style, and high-fat and -sugar diets are associated with the risk of night sweats and hot flushes in midlife: results from a prospective cohort study","volume":"97","author":"Herber-Gast","year":"2013","journal-title":"Am J Clin Nutr"},{"issue":"9","key":"10.1016\/j.eurox.2025.100366_bib28","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1097\/GME.0000000000001574","article-title":"Influence of dietary habits and Mediterranean diet adherence on menopausal symptoms. The FLAMENCO project","volume":"27","author":"Flor-Alemany","year":"2020","journal-title":"Menopause"},{"issue":"9","key":"10.1016\/j.eurox.2025.100366_bib29","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/gme.0b013e31824f606e","article-title":"Effects of a dietary intervention and weight change on vasomotor symptoms in the Women's Health Initiative","volume":"19","author":"Kroenke","year":"2012","journal-title":"Menopause"},{"issue":"1","key":"10.1016\/j.eurox.2025.100366_bib30","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/GME.0000000000002080","article-title":"A dietary intervention for vasomotor symptoms of menopause: a randomized, controlled trial","volume":"30","author":"Barnard","year":"2023","journal-title":"Menopause"},{"issue":"6","key":"10.1016\/j.eurox.2025.100366_bib31","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3109\/13697137.2015.1080236","article-title":"The association between hot flushes and smoking in midlife women: a meta-analysis","volume":"18","author":"Jenabi","year":"2015","journal-title":"Climacteric"},{"issue":"10","key":"10.1016\/j.eurox.2025.100366_bib32","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/GME.0000000000000434","article-title":"Risk factors for hot flashes among women undergoing the menopausal transition: baseline results from the Midlife Women's Health Study","volume":"22","author":"Gallicchio","year":"2015","journal-title":"Menopause"},{"issue":"9","key":"10.1016\/j.eurox.2025.100366_bib33","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/GME.0b013e3182844a7c","article-title":"Risk factors for night sweats and hot flushes in midlife: results from a prospective cohort study","volume":"20","author":"Herber-Gast","year":"2013","journal-title":"Menopause"},{"issue":"4","key":"10.1016\/j.eurox.2025.100366_bib34","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.maturitas.2011.09.011","article-title":"Symptom prevalence during menopause and factors associated with symptoms and menopausal age. Results from the Norwegian Hordaland Women's Cohort study","volume":"70","author":"Gjelsvik","year":"2011","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.eurox.2025.100366_bib35","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1471-0528.2011.03166.x","article-title":"Prevalence, frequency and problem rating of hot flushes persist in older postmenopausal women: impact of age, body mass index, hysterectomy, hormone therapy use, lifestyle and mood in a cross-sectional cohort study of 10,418 British women aged 54-65","volume":"119","author":"Hunter","year":"2012","journal-title":"BJOG"},{"issue":"11","key":"10.1016\/j.eurox.2025.100366_bib36","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.3390\/nu14112276","article-title":"Alcohol consumption patterns and risk of early-onset vasomotor symptoms in premenopausal women","volume":"14","author":"Kwon","year":"2022","journal-title":"Nutrients"},{"issue":"09","key":"10.1016\/j.eurox.2025.100366_bib37","doi-asserted-by":"crossref","first-page":"989","DOI":"10.4236\/health.2010.29146","article-title":"An exploratory study on perceived relationship of alcohol, caffeine, and physical activity on hot flashes in menopausal women","volume":"02","author":"Kandiah","year":"2010","journal-title":"Health"},{"issue":"9","key":"10.1016\/j.eurox.2025.100366_bib38","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1097\/GME.0000000000000206","article-title":"Relationship of sleep alterations with perimenopausal and postmenopausal symptoms","volume":"21","author":"Moreno-Fr\u00edas","year":"2014","journal-title":"Menopause"},{"issue":"7","key":"10.1016\/j.eurox.2025.100366_bib39","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1007\/s11606-004-0002-3","article-title":"Differential association of modifiable health behaviors with hot flashes in perimenopausal and postmenopausal women","volume":"19","author":"Hyde Riley","year":"2004","journal-title":"J Gen Intern Med"},{"issue":"5","key":"10.1016\/j.eurox.2025.100366_bib40","doi-asserted-by":"crossref","first-page":"478.e1","DOI":"10.1016\/j.ajog.2019.10.103","article-title":"Obesity, smoking, and risk of vasomotor menopausal symptoms: a pooled analysis of eight cohort studies","volume":"222","author":"Anderson","year":"2020","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.eurox.2025.100366_bib41","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.maturitas.2015.06.029","article-title":"Does quitting smoking decrease the risk of midlife hot flashes? A longitudinal analysis","volume":"82","author":"Smith","year":"2015","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.eurox.2025.100366_bib42","first-page":"29","article-title":"Risk factors for menopausal hot flashes","volume":"84","author":"Schwingl","year":"1994","journal-title":"Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.eurox.2025.100366_bib43","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1089\/jwh.1998.7.1149","article-title":"Predictors of menopausal hot flashes","volume":"7","author":"Staropoli","year":"1998","journal-title":"J Women\u2019s Health"},{"issue":"9","key":"10.1016\/j.eurox.2025.100366_bib44","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1097\/GME.0000000000001363","article-title":"Cognitive behavior therapy for menopausal symptoms (CBT-Meno): a randomized controlled trial","volume":"26","author":"Green","year":"2019","journal-title":"Menopause."},{"issue":"3","key":"10.1016\/j.eurox.2025.100366_bib45","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1017\/S0033291721005407","article-title":"Efficacy of cognitive therapy and behavior therapy for menopausal symptoms: a systematic review and meta-analysis","volume":"52","author":"Ye","year":"2022","journal-title":"Psychol Med"},{"issue":"2","key":"10.1016\/j.eurox.2025.100366_bib46","first-page":"255","article-title":"Intervenci\u00f3n cognitivo-conductual en sintomatolog\u00eda menop\u00e1usica: efectos a corto plazo [Cognitive-behavioral intervention in menopausal symptomatology: short-term effects]","volume":"21","author":"Larroy Garc\u00eda","year":"2009","journal-title":"Psicothema"},{"issue":"7","key":"10.1016\/j.eurox.2025.100366_bib47","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/gme.0b013e31823fe835","article-title":"Effectiveness of group and self-help cognitive behavior therapy in reducing problematic menopausal hot flushes and night sweats (MENOS 2): a randomized controlled trial","volume":"19","author":"Ayers","year":"2012","journal-title":"Menopause"},{"issue":"7","key":"10.1016\/j.eurox.2025.100366_bib48","article-title":"Relaxation for perimenopausal and postmenopausal symptoms","author":"Saensak","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.eurox.2025.100366_bib49","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/gme.0b013e31826ce3ed","article-title":"Clinical hypnosis in the treatment of postmenopausal hot flashes: a randomized controlled trial","volume":"20","author":"Elkins","year":"2013","journal-title":"Menopause"},{"issue":"7","key":"10.1016\/j.eurox.2025.100366_bib50","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1097\/GME.0000000000000837","article-title":"Efficacy of a biobehavioral intervention for hot flashes: a randomized controlled pilot study","volume":"24","author":"Barton","year":"2017","journal-title":"Menopause"},{"issue":"4","key":"10.1016\/j.eurox.2025.100366_bib51","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/GME.0b013e31829e4baa","article-title":"Efficacy of yoga for vasomotor symptoms: a randomized controlled trial","volume":"21","author":"Newton","year":"2014","journal-title":"Menopause"},{"issue":"3","key":"10.1016\/j.eurox.2025.100366_bib52","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/gme.0b013e31818ffe39","article-title":"Yoga for menopausal symptoms: a systematic review","volume":"16","author":"Lee","year":"2009","journal-title":"Menopause"},{"issue":"11","key":"10.1016\/j.eurox.2025.100366_bib53","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1080\/09513590.2019.1621835","article-title":"Acupuncture or phy(F)itoestrogens vs. (E)strogen plus progestin on menopausal symptoms. A randomized study","volume":"35","author":"Palma","year":"2019","journal-title":"Gynecol Endocrinol"},{"issue":"7","key":"10.1016\/j.eurox.2025.100366_bib54","article-title":"Acupuncture for menopausal hot flushes","volume":"2013","author":"Dodin","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.eurox.2025.100366_bib55","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/GME.0000000000001651","article-title":"Acupuncture ameliorated vasomotor symptoms during menopausal transition: single-blind, placebo-controlled, randomized trial to test treatment efficacy","volume":"28","author":"Soares","year":"2020","journal-title":"Menopause"},{"key":"10.1016\/j.eurox.2025.100366_bib56","doi-asserted-by":"crossref","first-page":"5584","DOI":"10.1200\/JCO.2007.12.0774","article-title":"Randomized, controlled trial of acupuncture for the treatment of hot flashes in breast cancer patients","volume":"25","author":"Deng","year":"2007","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.eurox.2025.100366_bib57","doi-asserted-by":"crossref","first-page":"146","DOI":"10.7326\/M15-1380","article-title":"Acupuncture for menopausal hot flashes: a randomized trial","volume":"164","author":"Ee","year":"2016","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.eurox.2025.100366_bib58","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/13697130410001713814","article-title":"A comparison of acupuncture and oral estradiol treatment of vasomotor symptoms in postmenopausal women","volume":"7","author":"Wyon","year":"2004","journal-title":"Climacteric"},{"issue":"1","key":"10.1016\/j.eurox.2025.100366_bib59","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/bcp.12935","article-title":"Defining 'nutraceuticals': neither nutritious nor pharmaceutical","volume":"83","author":"Aronson","year":"2017","journal-title":"Br J Clin Pharm"},{"issue":"2","key":"10.1016\/j.eurox.2025.100366_bib60","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/13697137.2020.1820477","article-title":"Review & meta-analysis: isopropanolic black cohosh extract iCR for menopausal symptoms \u2013 an update on the evidence","volume":"24","author":"Castelo-Branco","year":"2021","journal-title":"Climacteric"},{"issue":"1","key":"10.1016\/j.eurox.2025.100366_bib61","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1749-8546-8-20","article-title":"Efficacy of black cohosh (Cimicifuga racemosa L.) in treating early symptoms of menopause: a randomized clinical trial","volume":"8","author":"Mohammad-Alizadeh-Charandabi","year":"2013","journal-title":"Chin Med"},{"issue":"7-8","key":"10.1016\/j.eurox.2025.100366_bib62","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10354-016-0537-z","article-title":"60 years of Cimicifuga racemosa medicinal products: clinical research milestones, current study findings and current development","volume":"167","author":"Henneicke-von Zepelin","year":"2017","journal-title":"Wien Med Woche"},{"issue":"5","key":"10.1016\/j.eurox.2025.100366_bib63","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/09513590.2022.2056591","article-title":"on the behalf of the Natural Products Study Group of the Spanish Menopause Society. Black cohosh efficacy and safety for menopausal symptoms. The Spanish Menopause Society statement","volume":"38","author":"Castelo-Branco","year":"2022","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.eurox.2025.100366_bib64","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0029-7844(97)00597-8","article-title":"The effect of dietary soy supplementation on hot flushes","volume":"91","author":"Albertazzi","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.eurox.2025.100366_bib65","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/13697130008500108","article-title":"The effects of soy protein containing phytoestrogens on menopausal symptoms in postmenopausal women","volume":"3","author":"Kotsopoulos","year":"2000","journal-title":"Climacteric"},{"key":"10.1016\/j.eurox.2025.100366_bib66","first-page":"13","article-title":"Effects on menopausal symptoms and acceptability of isoflavone-containing soy powder dietary supplementation","volume":"4","author":"Knight","year":"2001","journal-title":"Climacteric 2001"},{"key":"10.1016\/j.eurox.2025.100366_bib67","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/01.gme.0000191882.59799.67","article-title":"A randomized controlled trial of the effect of dietary soy and flaxseed muffins on quality of life and hot flashes during menopause","volume":"13","author":"Lewis","year":"2006","journal-title":"Menopause"},{"key":"10.1016\/j.eurox.2025.100366_bib68","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/GME.0b013e31802cc7d0","article-title":"Isoflavone treatment for acute menopausal symptoms","volume":"14","author":"Cheng","year":"2007","journal-title":"Menopause"},{"key":"10.1016\/j.eurox.2025.100366_bib69","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/00042192-200007040-00005","article-title":"Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study","volume":"7","author":"Upmalis","year":"2000","journal-title":"Menopause"},{"key":"10.1016\/j.eurox.2025.100366_bib70","first-page":"389","article-title":"Benefits of soy isoflavone therapeutic regimen on menopausal symptoms","volume":"99","author":"Soares","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.eurox.2025.100366_bib71","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00042192-200209000-00005","article-title":"Effects of a standardized soy extract on hot flushes: a multicenter, double-blind, randomized, placebo-controlled study","volume":"9","author":"Faure","year":"2002","journal-title":"Menopause"},{"key":"10.1016\/j.eurox.2025.100366_bib72","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S0015-0282(03)00158-4","article-title":"Effect of soy-derived isoflavones on hot flushes, endometrial thickness, and the pulsatility index of the uterine and cerebral arteries","volume":"79","author":"Penotti","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.eurox.2025.100366_bib73","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.maturitas.2003.09.026","article-title":"Benefits of soy germ isoflavones in postmenopausal women with contraindication for conventional hormone replacement therapy","volume":"48","author":"Petri Nahas","year":"2004","journal-title":"Maturitas"},{"key":"10.1016\/j.eurox.2025.100366_bib74","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.maturitas.2004.11.002","article-title":"Polyunsaturated fatty acids (PUFAs) might reduce hot flushes: an indication from two controlled trials on soy isoflavones alone and with a PUFA supplement","volume":"51","author":"Campagnoli","year":"2005","journal-title":"Maturitas"},{"key":"10.1016\/j.eurox.2025.100366_bib75","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.maturitas.2007.08.012","article-title":"Efficacy and safety of a soy isoflavone extract in postmenopausal women: a randomized, double-blind, and placebo-controlled study","volume":"58","author":"Nahas","year":"2007","journal-title":"Maturitas"},{"issue":"6","key":"10.1016\/j.eurox.2025.100366_bib76","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1447-0756.2009.01058.x","article-title":"Soy extract phytoestrogens with high dose of isoflavones for menopausal symptoms","volume":"35","author":"Ferrari","year":"2009","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.eurox.2025.100366_bib77","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/01.GME.0000109314.11228.E5","article-title":"Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and placebo-controlled study","volume":"11","author":"Crisafulli","year":"2004","journal-title":"Menopause"},{"key":"10.1016\/j.eurox.2025.100366_bib78","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/13697130500345257","article-title":"Effect of pure genistein on bone markers and hot flushes","volume":"8","author":"Albertazzi","year":"2005","journal-title":"Climacteric"},{"key":"10.1016\/j.eurox.2025.100366_bib79","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.maturitas.2010.11.012","article-title":"The effect of synthetic genistein on menopause symptom management in healthy postmenopausal women: a multi-center, randomized, placebo-controlled study","volume":"68","author":"Evans","year":"2011","journal-title":"Maturitas"},{"key":"10.1016\/j.eurox.2025.100366_bib80","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/01.gme.0000248708.60698.98","article-title":"Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study","volume":"14","author":"D'Anna","year":"2007","journal-title":"Menopause"},{"key":"10.1016\/j.eurox.2025.100366_bib81","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/13697139909025570","article-title":"The effect of Promensil, an isoflavone extract, on menopausal symptoms","volume":"2","author":"Knight","year":"1999","journal-title":"Climacteric"},{"issue":"3","key":"10.1016\/j.eurox.2025.100366_bib82","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0378-5122(02)00080-4","article-title":"Isoflavones from red clover (Promensil) significantly reduce menopausal hot flush symptoms compared with placebo","volume":"42","author":"van de Weijer","year":"2002","journal-title":"Maturitas"},{"issue":"8","key":"10.1016\/j.eurox.2025.100366_bib83","first-page":"35","article-title":"The use of isoflavone supplement to relieve hot flashes","volume":"27","author":"Jeri","year":"2002","journal-title":"Female Patient"},{"issue":"2","key":"10.1016\/j.eurox.2025.100366_bib84","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1001\/jama.290.2.207","article-title":"Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trial","volume":"290","author":"Tice","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.eurox.2025.100366_bib85","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/09513590500361192","article-title":"The effect of red clover isoflavones on menopausal symptoms, lipids and vaginal cytology in menopausal women: a randomized, double-blind, placebo-controlled study","volume":"21","author":"Hidalgo","year":"2005","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"10.1016\/j.eurox.2025.100366_bib86","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/gme.0b013e3181cb4fb5","article-title":"Soy isoflavones versus placebo in the treatment of climacteric vasomotor symptoms: systematic review and meta-analysis","volume":"17","author":"Bola\u00f1os","year":"2010","journal-title":"Menopause"},{"key":"10.1016\/j.eurox.2025.100366_bib87","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/gme.0b013e3182410159","article-title":"Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: systematic review and meta-analysis of randomized controlled trials","volume":"19","author":"Taku","year":"2012","journal-title":"Menopause"},{"issue":"6","key":"10.1016\/j.eurox.2025.100366_bib88","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/GME.0000000000002200","article-title":"The 2023 nonhormone therapy position statement of The North American Menopause Society","volume":"30","year":"2023","journal-title":"Menopause"},{"key":"10.1016\/j.eurox.2025.100366_bib89","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.maturitas.2005.10.005","article-title":"A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts","volume":"54","author":"Heyerick","year":"2006","journal-title":"Maturitas"},{"key":"10.1016\/j.eurox.2025.100366_bib90","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.phymed.2010.01.007","article-title":"A randomized, double-blind, placebo-controlled, cross-over pilot study onthe use of a standardized hop extract to alleviate menopausal discomforts","volume":"17","author":"Erkkola","year":"2010","journal-title":"Phytomed"},{"key":"10.1016\/j.eurox.2025.100366_bib91","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ctcp.2015.05.001","article-title":"The effect of Hop (Humulus lupulus L.) on early menopausal symptoms and hot flashes: a randomized placebo-controlled trial","volume":"23","author":"Aghamiri","year":"2016","journal-title":"Complement Ther Clin Pr"},{"key":"10.1016\/j.eurox.2025.100366_bib92","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.4103\/jfmpc.jfmpc_913_19","article-title":"The effect of Salvia officinalis extract on symptoms of flushing, night sweat, sleep disorders, and score of forgetfulness in postmenopausal women","volume":"9","author":"Zeidabadi","year":"2020","journal-title":"J Fam Med Prim Care"},{"issue":"2","key":"10.1016\/j.eurox.2025.100366_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e05910","article-title":"Effectiveness of Menosan\u00ae Salvia officinalis in the treatment of a wide spectrum of menopausal complaints. A double-blind, randomized, placebo-controlled, clinical trial","volume":"7","author":"Wilfried","year":"2021","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/j.eurox.2025.100366_bib94","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/13697130500117987","article-title":"Femal\u00ae, an herbal remedy made from pollen extracts, reduces hot flushes and improves quality of life in menopausal women: a randomized, placebo-controlled, parallel study","volume":"8","author":"Winther","year":"2005","journal-title":"Climateric"},{"issue":"3","key":"10.1016\/j.eurox.2025.100366_bib95","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1080\/09513590.2020.1722994","article-title":"Purified and specific cytoplasmic pollen extract: a non-hormonal alternative for the treatment of menopausal symptoms","volume":"36","author":"Genazzani","year":"2020","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"10.1016\/j.eurox.2025.100366_bib96","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1080\/09513590.2018.1538347","article-title":"Prospective observational study to evaluate the efficacy and safety of the pollen extract S\u00e9r\u00e9lys\u00ae in the management of women with menopausal symptoms","volume":"35","author":"Fait","year":"2019","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"10.1016\/j.eurox.2025.100366_bib97","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/GME.0000000000000756","article-title":"Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study","volume":"24","author":"Santoro","year":"2017","journal-title":"Menopause"},{"issue":"1","key":"10.1016\/j.eurox.2025.100366_bib98","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/01.GME.0000074705.98544.16","article-title":"Low-dose transdermal estradiol for symptomatic perimenopause","volume":"11","author":"Shulman","year":"2004","journal-title":"Menopause"},{"issue":"4","key":"10.1016\/j.eurox.2025.100366_bib99","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/01.AOG.0000284450.51264.31","article-title":"Lowest effective transdermal 17beta-estradiol dose for relief of hot flushes in postmenopausal women: a randomized controlled trial","volume":"110","author":"Bachmann","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.eurox.2025.100366_bib100","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0002-9378(99)70438-2","article-title":"Efficacy and safety of low, standard, and high dosages of an estradiol transdermal system (Esclim) compared with placebo on vasomotor symptoms in highly symptomatic menopausal patients","volume":"181","author":"Utian","year":"1999","journal-title":"Esclim Study Group Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.eurox.2025.100366_bib101","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/01.AOG.0000254160.62588.41","article-title":"Low dose of transdermal estradiol gel for treatment of symptomatic postmenopausal women: a randomized controlled trial","volume":"109","author":"Simon","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"1-2","key":"10.1016\/j.eurox.2025.100366_bib102","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0378-5122(96)01029-8","article-title":"A randomized, double-blind, multicentre study comparing the clinical effects of two sequential estradiol-progestin combinations containing either desogestrel or norethisterone acetate in climacteric women with estrogen deficiency symptoms","volume":"24","author":"Saure","year":"1996","journal-title":"Maturitas"},{"issue":"3","key":"10.1016\/j.eurox.2025.100366_bib103","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/13697139809085544","article-title":"Do combinations of 1 mg estradiol and low doses of NETA effectively control menopausal symptoms?","volume":"1","author":"Baerug","year":"1998","journal-title":"Climacteric"},{"issue":"6","key":"10.1016\/j.eurox.2025.100366_bib104","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0015-0282(01)01791-5","article-title":"Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate","volume":"75","author":"Utian","year":"2001","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.eurox.2025.100366_bib105","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0378-5122(02)00203-7","article-title":"Bleeding patterns in peri and postmenopausal women taking a continuous combined regimen of estradiol with norethisterone acetate or a conventional sequential regimen of conjugated equine estrogens with medrogestone","volume":"43","author":"von Holst","year":"2002","journal-title":"Maturitas"},{"issue":"2","key":"10.1016\/j.eurox.2025.100366_bib106","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/humupd\/dmy039","article-title":"The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review","volume":"25","author":"Oliver-Williams","year":"2019","journal-title":"Hum Reprod Update"},{"issue":"3","key":"10.1016\/j.eurox.2025.100366_bib107","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3109\/13697137.2014.999661","article-title":"Study Group. Ultra-low-dose estradiol and norethisterone acetate: bleeding patterns and other outcomes over 52 weeks of therapy","volume":"18","author":"Mattsson","year":"2015","journal-title":"Climacteric"},{"issue":"6","key":"10.1016\/j.eurox.2025.100366_bib108","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1080\/13697137.2020.1806816","article-title":"Uterine bleeding with hormone therapies in menopausal women: a systematic review","volume":"23","author":"Pickar","year":"2020","journal-title":"Climacteric"},{"issue":"4","key":"10.1016\/j.eurox.2025.100366_bib109","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/GME.0000000000001480","article-title":"Endometrial safety and bleeding profile of a 17\u03b2-estradiol\/progesterone oral softgel capsule (TX-001HR)","volume":"27","author":"Mirkin","year":"2020","journal-title":"Menopause"},{"issue":"12","key":"10.1016\/j.eurox.2025.100366_bib110","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1097\/GME.0000000000001615","article-title":"17\u03b2-estradiol\/progesterone in a single, oral, softgel capsule (TX-001HR) significantly increased the number of vasomotor symptom-free days in the REPLENISH trial","volume":"27","author":"Kaunitz","year":"2020","journal-title":"Menopause"},{"issue":"8","key":"10.1016\/j.eurox.2025.100366_bib111","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1080\/17512433.2019.1637731","article-title":"A combined, bioidentical, oral, 17\u03b2-estradiol and progesterone capsule for the treatment of moderate to severe vasomotor symptoms due to menopause","volume":"12","author":"Archer","year":"2019","journal-title":"Expert Rev Clin Pharm"},{"issue":"2","key":"10.1016\/j.eurox.2025.100366_bib112","doi-asserted-by":"crossref","first-page":"49","DOI":"10.6118\/jmm.20038","article-title":"Levonorgestrel-releasing intrauterine system use in perimenopausal women","volume":"27","author":"Joo","year":"2021","journal-title":"J Menopausa Med"},{"issue":"1","key":"10.1016\/j.eurox.2025.100366_bib113","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0378-5122(03)00163-4","article-title":"Continuous intrauterine compared with cyclic oral progestin administration in perimenopausal HRT","volume":"46","author":"Boon","year":"2003","journal-title":"Maturitas"},{"issue":"6","key":"10.1016\/j.eurox.2025.100366_bib114","first-page":"963","article-title":"Intrauterine release of levonorgestrel--a new way of adding progestogen in hormone replacement therapy","volume":"79","author":"Andersson","year":"1992","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.eurox.2025.100366_bib115","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3109\/13697137.2014.991302","article-title":"The levonorgestrel-releasing intrauterine system for endometrial protection during estrogen replacement therapy: a clinical review","volume":"18","author":"Depypere","year":"2015","journal-title":"Climacteric"},{"key":"10.1016\/j.eurox.2025.100366_bib116","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/00016349709050071","article-title":"Three-year follow-up of the use of a levonorgestrel-releasing intrauterine system in hormone replacement therapy","volume":"76","author":"Suhonen","year":"1997","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"10.1016\/j.eurox.2025.100366_bib117","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0378-5122(03)00163-4","article-title":"Continuous intrauterine compared with cyclic oral progestin administration in perimenopausal HRT","volume":"46","author":"Boon","year":"2003","journal-title":"Maturitas"},{"issue":"7","key":"10.1016\/j.eurox.2025.100366_bib118","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/CIRCULATIONAHA.106.642280","article-title":"Estrogen and Thromboembolism Risk (ESTHER) Study Group. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study","volume":"115","author":"Canonico","year":"2007","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.eurox.2025.100366_bib119","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1210\/clinem\/dgab042","article-title":"Menopausal hormone therapy and cardiovascular disease: the role of formulation, dose, and route of delivery","volume":"106","author":"Shufelt","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eurox.2025.100366_bib120","doi-asserted-by":"crossref","first-page":"k4810","DOI":"10.1136\/bmj.k4810","article-title":"Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases","volume":"364","author":"Vinogradova","year":"2019","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.eurox.2025.100366_bib121","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/01.gme.0000247016.41007.c9","article-title":"Tibolone for the treatment of moderate to severe vasomotor symptoms and genital atrophy in postmenopausal women: a multicenter, randomized, double-blind, placebo-controlled study","volume":"13","author":"Swanson","year":"2006","journal-title":"Menopause"},{"issue":"7","key":"10.1016\/j.eurox.2025.100366_bib122","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1097\/GME.0b013e31827b18c5","article-title":"Spanish Menopause Society position statement: use of tibolone in postmenopausal women","volume":"20","author":"Mendoza","year":"2013","journal-title":"Menopause"},{"issue":"2","key":"10.1016\/j.eurox.2025.100366_bib123","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.genm.2011.03.008","article-title":"Treating menopausal symptoms with a tissue-selective estrogen complex","volume":"8","author":"Levine","year":"2011","journal-title":"Gend Med"},{"issue":"8","key":"10.1016\/j.eurox.2025.100366_bib124","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/gme.0b013e318247f07a","article-title":"Oral micronized progesterone for vasomotor symptoms--a placebo-controlled randomized trial in healthy postmenopausal women","volume":"19","author":"Hitchcock","year":"2012","journal-title":"Menopause"},{"issue":"2","key":"10.1016\/j.eurox.2025.100366_bib125","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/GME.0000000000001676","article-title":"Efficacy of progestin-only treatment for the management of menopausal symptoms: a systematic review","volume":"28","author":"Dolitsky","year":"2020","journal-title":"Menopause"},{"issue":"1","key":"10.1016\/j.eurox.2025.100366_bib126","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/13697137.2020.1862079","article-title":"Bioidentical hormones","volume":"24","author":"Stanczyk","year":"2021","journal-title":"Climacteric"},{"issue":"5","key":"10.1016\/j.eurox.2025.100366_bib127","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1089\/jwh.2012.4200","article-title":"Factors associated with successful discontinuation of hormone therapy","volume":"23","author":"Newton","year":"2014","journal-title":"J Women\u2019s Health (Larchmt)"},{"issue":"2","key":"10.1016\/j.eurox.2025.100366_bib128","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/jama.294.2.183","article-title":"Symptom experience after discontinuing use of estrogen plus progestin","volume":"294","author":"Ockene","year":"2005","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.eurox.2025.100366_bib129","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/gme.0b013e3181b397c7","article-title":"A randomized controlled study of taper-down or abrupt discontinuation of hormone therapy in women treated for vasomotor symptoms","volume":"17","author":"Lindh-Astrand","year":"2010","journal-title":"Menopause"},{"issue":"12","key":"10.1016\/j.eurox.2025.100366_bib130","doi-asserted-by":"crossref","first-page":"5893","DOI":"10.1210\/jc.2019-00677","article-title":"Treatment of menopausal vasomotor symptoms with fezolinetant, a neurokinin 3 receptor antagonist: a phase 2a trial","volume":"104","author":"Depypere","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eurox.2025.100366_bib131","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/GME.0000000000001510","article-title":"A phase 2b, randomized, placebo-controlled, double-blind, dose-ranging study of the neurokinin 3 receptor antagonist fezolinetant for vasomotor symptoms associated with menopause","volume":"27","author":"Fraser","year":"2020","journal-title":"Menopause (NY)"},{"issue":"10382","key":"10.1016\/j.eurox.2025.100366_bib132","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0140-6736(23)00085-5","article-title":"Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomized controlled study","volume":"401","author":"Lederman","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.eurox.2025.100366_bib133","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgad058","article-title":"Efficacy and safety of fezolinetant in moderate-to-severe vasomotor symptoms associated with menopause: a phase 3 RCT","author":"Johnson","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eurox.2025.100366_bib134","first-page":"737","article-title":"Safety of fezolinetant for vasomotor symptoms associated with menopause: a randomized controlled trial","volume":"141","author":"Neal-Perry","year":"2023","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.eurox.2025.100366_bib135","doi-asserted-by":"crossref","DOI":"10.1177\/03000605241247684","article-title":"Efficacy and safety of fezolinetant for moderate to severe vasomotor symptoms associated with menopause among women in East Asia: a phase 3 randomized study (MOONLIGHT I)","volume":"52","author":"Ruan","year":"2024","journal-title":"J Int Med Res"},{"issue":"5","key":"10.1016\/j.eurox.2025.100366_bib136","doi-asserted-by":"crossref","DOI":"10.1177\/03000605241246624","article-title":"Long-term safety of fezolinetant in Chinese women with vasomotor symptoms associated with menopause: the phase 3 open-label MOONLIGHT 3 clinical trial","volume":"52","author":"Yu","year":"2024","journal-title":"J Int Med Res"},{"issue":"9","key":"10.1016\/j.eurox.2025.100366_bib137","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1111\/1471-0528.17773","article-title":"Fezolinetant impact on health-related quality of life for vasomotor symptoms due to the menopause: pooled data from SKYLIGHT 1 and SKYLIGHT 2 randomised controlled trials","volume":"131","author":"Cano","year":"2024","journal-title":"BJOG"},{"issue":"3","key":"10.1016\/j.eurox.2025.100366_bib138","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/AOG.0000000000005508","article-title":"Efficacy and safety of fezolinetant for the treatment of menopause-associated vasomotor symptoms: a meta-analysis","volume":"143","author":"Bonga","year":"2024","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.eurox.2025.100366_bib139","doi-asserted-by":"crossref","DOI":"10.1016\/j.maturitas.2024.107999","article-title":"Effect of fezolinetant on sleep disturbance and impairment during treatment of vasomotor symptoms due to menopause","volume":"186","author":"Shapiro","year":"2024","journal-title":"Maturitas"},{"issue":"4","key":"10.1016\/j.eurox.2025.100366_bib140","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/GME.0000000000002340","article-title":"Fezolinetant treatment of moderate-to-severe vasomotor symptoms due to menopause: effect of intrinsic and extrinsic factors in two phase 3 studies (SKYLIGHT 1 and 2)","volume":"31","author":"Santoro","year":"2024","journal-title":"Menopause"},{"issue":"1","key":"10.1016\/j.eurox.2025.100366_bib141","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/GME.0000000000002281","article-title":"Systematic review and network meta-analysis comparing the efficacy of fezolinetant with hormone and nonhormone therapies for treatment of vasomotor symptoms due to menopause","volume":"31","author":"Morga","year":"2024","journal-title":"Menopause"},{"issue":"3","key":"10.1016\/j.eurox.2025.100366_bib142","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/GME.0000000000002138","article-title":"Efficacy and safety of elinzanetant, a selective neurokinin-1, 3 receptor antagonist for vasomotor symptoms: a dose-finding clinical trial (SWITCH-1)","volume":"30","author":"Simon","year":"2023","journal-title":"Menopause (NY)"},{"issue":"8","key":"10.1016\/j.eurox.2025.100366_bib143","doi-asserted-by":"crossref","first-page":"e3221","DOI":"10.1210\/clinem\/dgab108","article-title":"Elinzanetant (NT-814), a Neurokinin 1,3 receptor antagonist, reduces estradiol and progesterone in healthy women","volume":"106","author":"Pawsey","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eurox.2025.100366_bib144","doi-asserted-by":"crossref","unstructured":"Pinkerton J., Panay N., Caetano C., Seitz C., Zuurman L., Simon J.A., editors. Design of OASIS-1 and-2: Phase 3 Trials to Assess the Efficacy and Safety of Elinzanetant for the Treatment of Vasomotor Symptoms Related to Menopause. doi: 10.1097\/GME.0000000000002350.","DOI":"10.1097\/GME.0000000000002350"},{"issue":"3","key":"10.1016\/j.eurox.2025.100366_bib145","first-page":"173","article-title":"The efficacy and safety of selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors in the treatment of menopausal hot flashes: a systematic review of clinical trials","volume":"47","author":"Azizi","year":"2022","journal-title":"Iran J Med Sci"},{"key":"10.1016\/j.eurox.2025.100366_bib146","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/GME.0000000000000311","article-title":"Low-dose paroxetine (7.5 mg) improves sleep in women with vasomotor symptoms associated with menopause","volume":"22","author":"Pinkerton","year":"2015","journal-title":"Menopause"},{"key":"10.1016\/j.eurox.2025.100366_bib147","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2147\/IJWH.S282396","article-title":"A clinical review on paroxetine and emerging therapies for the treatment of vasomotor symptoms","volume":"14","author":"David","year":"2022","journal-title":"Int J Women\u2019s Health"},{"key":"10.1016\/j.eurox.2025.100366_bib148","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1097\/GME.0000000000000210","article-title":"E\ufb00ects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause","volume":"21","author":"Portman","year":"2014","journal-title":"Menopause"},{"issue":"17","key":"10.1016\/j.eurox.2025.100366_bib149","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1001\/jama.295.17.2057","article-title":"Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis","volume":"295","author":"Nelson","year":"2006","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.eurox.2025.100366_bib150","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s11606-013-2535-9","article-title":"SSRIs for hot flashes: a systematic review and meta-analysis of randomized trials","volume":"29","author":"Shams","year":"2014","journal-title":"J Gen Intern Med"},{"issue":"9","key":"10.1016\/j.eurox.2025.100366_bib151","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3390\/medicina55090554","article-title":"Efficacy of low-dose paroxetine for the treatment of hot flushes in surgical and physiological postmenopausal women: systematic review and meta-analysis of randomized trials","volume":"55","author":"Riemma","year":"2019","journal-title":"Medicina"},{"issue":"21","key":"10.1016\/j.eurox.2025.100366_bib152","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1001\/jama.289.21.2827","article-title":"Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial","volume":"289","author":"Stearns","year":"2003","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.eurox.2025.100366_bib153","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.amjmed.2007.10.007","article-title":"Paroxetine versus placebo for women in midlife after hormone therapy discontinuation","volume":"121","author":"Soares","year":"2008","journal-title":"Am J Med"},{"issue":"9","key":"10.1016\/j.eurox.2025.100366_bib154","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/GME.0000000000000218","article-title":"Diary of hot flashes reported upon occurrence: results of a randomized double-blind study of raloxifene, placebo, and paroxetine","volume":"21","author":"Simon","year":"2014","journal-title":"Menopause"},{"issue":"1","key":"10.1016\/j.eurox.2025.100366_bib155","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijgo.2015.04.042","article-title":"A crossover study comparing gabapentin and fluoxetine for the treatment of vasomotor symptoms among postmenopausal women","volume":"131","author":"Rahmanian","year":"2015","journal-title":"Int J Gynaecol Obstet"},{"issue":"6","key":"10.1016\/j.eurox.2025.100366_bib156","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1200\/JCO.2002.20.6.1578","article-title":"Phase III evaluation of fluoxetine for treatment of hot flashes","volume":"20","author":"Loprinzi","year":"2002","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.eurox.2025.100366_bib157","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00042192-200512010-00006","article-title":"Citalopram and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study","volume":"12","author":"Suvanto-Luukkonen","year":"2005","journal-title":"Menopause"},{"issue":"2","key":"10.1016\/j.eurox.2025.100366_bib158","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/BF02849914","article-title":"Black cohosh and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized trial","volume":"24","author":"Oktem","year":"2007","journal-title":"Adv Ther"},{"issue":"7","key":"10.1016\/j.eurox.2025.100366_bib159","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1001\/jamainternmed.2014.1891","article-title":"Low-dose estradiol, and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial","volume":"174","author":"Joffe","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"4","key":"10.1016\/j.eurox.2025.100366_bib160","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000348564","article-title":"Efficacy, and safety of desvenlafaxine treatment for hot flashes associated with menopause: a meta-analysis of randomized controlled trials","volume":"75","author":"Sun","year":"2013","journal-title":"Gynecol Obstet Invest"},{"issue":"1","key":"10.1016\/j.eurox.2025.100366_bib161","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/gme.0b013e31826421a8","article-title":"Study 3353 Investigators. Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial","volume":"20","author":"Pinkerton","year":"2013","journal-title":"Menopause"},{"issue":"1","key":"10.1016\/j.eurox.2025.100366_bib162","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/gme.0b013e318274699f","article-title":"Maintenance of the efficacy of desvenlafaxine in menopausal vasomotor symptoms: a 1-year randomized controlled trial","volume":"20","author":"Pinkerton","year":"2013","journal-title":"Menopause"},{"issue":"3","key":"10.1016\/j.eurox.2025.100366_bib163","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4314\/ejhs.v24i3.4","article-title":"Is desvenlafaxine effective and safe in the treatment of menopausal vasomotor symptoms? A meta-analysis and meta-regression of randomized double-blind controlled studies","volume":"24","author":"Berhan","year":"2014","journal-title":"Ethiop J Health Sci"},{"issue":"6","key":"10.1016\/j.eurox.2025.100366_bib164","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.fertnstert.2012.03.001","article-title":"Effect of escitalopram on hot flash interference: a randomized, controlled trial","volume":"97","author":"Carpenter","year":"2012","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.eurox.2025.100366_bib165","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/annonc\/mdl478","article-title":"Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients--a double-blind, randomized study","volume":"18","author":"Loibl","year":"2007","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.eurox.2025.100366_bib166","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/GME.0000000000001491","article-title":"Gabapentin for the treatment of hot flushes in menopause: a meta-analysis","volume":"27","author":"Yoon","year":"2020","journal-title":"Menopause"},{"issue":"2","key":"10.1016\/j.eurox.2025.100366_bib167","first-page":"337","article-title":"Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trial","volume":"101","author":"Guttuso","year":"2003","journal-title":"Obstet Gynecol"},{"issue":"9488","key":"10.1016\/j.eurox.2025.100366_bib168","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0140-6736(05)67215-7","article-title":"Gabapentin for hot flashes in 420 women with breast cancer: a randomized double-blind placebo-controlled trial","volume":"366","author":"Pandya","year":"2005","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.eurox.2025.100366_bib169","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.AOG.0000222383.43913.ed","article-title":"Gabapentin, estrogen, and placebo for treating hot flushes: a randomized controlled trial","volume":"108","author":"Reddy","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.eurox.2025.100366_bib170","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/gme.0b013e3180dca175","article-title":"Gabapentin for the treatment of menopausal hot flashes: a randomized controlled trial","volume":"15","author":"Butt","year":"2008","journal-title":"Menopause"},{"issue":"5","key":"10.1016\/j.eurox.2025.100366_bib171","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3109\/09513590903511539","article-title":"Gabapentin vs. low-dose transdermal estradiol for treating post-menopausal women with moderate to very severe hot flushes","volume":"26","author":"Aguirre","year":"2010","journal-title":"Gynecol Endocrinol"},{"issue":"6","key":"10.1016\/j.eurox.2025.100366_bib172","doi-asserted-by":"crossref","first-page":"126","DOI":"10.5539\/gjhs.v5n6p126","article-title":"The effect of gabapentin on intensity and duration of hot flashes in postmenopausal women: a randomized controlled trial","volume":"5","author":"Saadati","year":"2013","journal-title":"Glob J Health Sci"},{"issue":"6","key":"10.1016\/j.eurox.2025.100366_bib173","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/GME.0b013e3182a7c073","article-title":"Breeze 3 Investigators. Phase 3 randomized controlled study of gastroretentive gabapentin for the treatment of moderate-to-severe hot flashes in menopause","volume":"21","author":"Pinkerton","year":"2014","journal-title":"Menopause"},{"issue":"1","key":"10.1016\/j.eurox.2025.100366_bib174","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/1754045313518527","article-title":"Evaluation of gabapentin in management of hot flushes in postmenopausal women","volume":"20","author":"Agarwal","year":"2014","journal-title":"Post Reprod Health"},{"issue":"3","key":"10.1016\/j.eurox.2025.100366_bib175","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10549-008-0138-7","article-title":"Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized cross-over study","volume":"115","author":"Buijs","year":"2009","journal-title":"Breast Cancer Res Treat"},{"issue":"29","key":"10.1016\/j.eurox.2025.100366_bib176","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1200\/JCO.2010.33.1298","article-title":"Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial","volume":"29","author":"Boekhout","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eurox.2025.100366_bib177","unstructured":"https:\/\/botplusweb.farmaceuticos.com\/. Access with key."},{"issue":"16","key":"10.1016\/j.eurox.2025.100366_bib178","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1001\/jama.2024.14618","article-title":"Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause: OASIS 1 and 2 Randomized Clinical Trials","volume":"332","author":"Pinkerton","year":"2024","journal-title":"JAMA"}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259016132500002X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259016132500002X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T04:44:02Z","timestamp":1742445842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S259016132500002X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":178,"alternative-id":["S259016132500002X"],"URL":"https:\/\/doi.org\/10.1016\/j.eurox.2025.100366","relation":{},"ISSN":["2590-1613"],"issn-type":[{"value":"2590-1613","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of menopausal hot flushes. Recommendations from the Spanish Menopause Society","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eurox.2025.100366","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100366"}}